ES8401075A1 - "procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas". - Google Patents

"procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas".

Info

Publication number
ES8401075A1
ES8401075A1 ES512275A ES512275A ES8401075A1 ES 8401075 A1 ES8401075 A1 ES 8401075A1 ES 512275 A ES512275 A ES 512275A ES 512275 A ES512275 A ES 512275A ES 8401075 A1 ES8401075 A1 ES 8401075A1
Authority
ES
Spain
Prior art keywords
hydrogen
hypertensive
substituted
procedure
alcohyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512275A
Other languages
English (en)
Other versions
ES512275A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES8401075A1 publication Critical patent/ES8401075A1/es
Publication of ES512275A0 publication Critical patent/ES512275A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE ESPIRO PIPERIDINO-OXOBENZOXACINAS SUSTITUIDAS EN POSICION 1 ANTI-HIPERTENSIVAS, DE FORMULA GENERAL (I), EN LA QUE R1, R2, R3 Y R4 SON, CADA UNO DE ELLOS INDEPENDIENTEMENTE, HIDROGENO, HIDROXI O HALO; R ES HIDROGENO O ALCOHILO INFERIOR; Y A SE SELECCIONA ENTRE 2-(BENZODIOXAN-2-IL)-2-HIDROXIETILO, 3-(ARILOXI)-2-HIDROXIPROPILO, V-ARILALCOHILO Y V-ARIL-V-OXO-ALCOHILO, Y SUS SALES DE ADICION DE ACIDOS FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN TRATAR UN COMPUESTO DE FORMULA (II), EN DONDE R1, R2, R3 Y R4 TIENEN LOS SIGNIFICADOS YA INDICADOS;Y R ES HIDROGENO O ALCOHILO INFERIOR, CON UN COMPUESTO SELECCIONADO DEL GRUPO DE FORMULA (III), EN DONDE A ES V-(BENZODIOXAN-2-IL)-ALCO HILO, V-ARILOXIALCOHILO O V-ARIL-V-OXO-ALCOHILO.DE APLICACION EN EL TRATAMIENTO DE LA HIPERTENSION.
ES512275A 1981-05-18 1982-05-17 "procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas". Granted ES512275A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/264,779 US4349549A (en) 1981-05-18 1981-05-18 Anti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)s

Publications (2)

Publication Number Publication Date
ES8401075A1 true ES8401075A1 (es) 1983-12-01
ES512275A0 ES512275A0 (es) 1983-12-01

Family

ID=23007572

Family Applications (3)

Application Number Title Priority Date Filing Date
ES512275A Granted ES512275A0 (es) 1981-05-18 1982-05-17 "procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas".
ES521125A Granted ES521125A0 (es) 1981-05-18 1983-03-30 Procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas.
ES521124A Granted ES521124A0 (es) 1981-05-18 1983-03-30 Procedimiento para preparar espino (piperidino-oxobenzo-xazinas) substituidas en posicion 1 anti-hipertensivas.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES521125A Granted ES521125A0 (es) 1981-05-18 1983-03-30 Procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas.
ES521124A Granted ES521124A0 (es) 1981-05-18 1983-03-30 Procedimiento para preparar espino (piperidino-oxobenzo-xazinas) substituidas en posicion 1 anti-hipertensivas.

Country Status (20)

Country Link
US (1) US4349549A (es)
EP (1) EP0065864B1 (es)
JP (1) JPS57193485A (es)
KR (1) KR830010115A (es)
AT (1) ATE15198T1 (es)
AU (1) AU8376982A (es)
BR (1) BR8202861A (es)
DE (1) DE3265802D1 (es)
DK (1) DK221882A (es)
ES (3) ES512275A0 (es)
FI (1) FI821733A7 (es)
HU (1) HU186933B (es)
IE (1) IE53034B1 (es)
IL (1) IL65801A (es)
NO (1) NO821616L (es)
NZ (1) NZ200631A (es)
PH (1) PH20072A (es)
PL (2) PL236472A1 (es)
PT (1) PT74912B (es)
ZA (1) ZA823414B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5815979A (ja) * 1981-07-11 1983-01-29 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体およびその製造法
JPS5959685A (ja) * 1982-09-28 1984-04-05 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
US4558049A (en) * 1982-11-24 1985-12-10 Farmitalia Carlo Erba S.P.A. Antipsycotic benzoxazines
GB2131021B (en) * 1982-11-24 1985-12-18 Erba Farmitalia Antipsychotic benzoxazines
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
US6374762B1 (en) * 1997-10-27 2002-04-23 Correct Craft, Inc. Water sport towing apparatus
AU2274101A (en) * 1999-12-21 2001-07-03 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
WO2001057044A1 (en) * 2000-02-01 2001-08-09 Daiichi Pharmaceutical Co., Ltd. Pyridoxazine derivatives
KR20070046929A (ko) * 2004-08-19 2007-05-03 버텍스 파마슈티칼스 인코포레이티드 무스카린 수용체 조절제
US7786141B2 (en) * 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
RU2007124373A (ru) * 2004-11-29 2009-01-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Модуляторы мускариновых рецептеров
JP2009521483A (ja) * 2005-12-22 2009-06-04 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
US7351706B2 (en) * 2006-01-05 2008-04-01 Hoffmann-La Roche Inc. Indol-3-yl-carbonyl-spiro-piperidine derivatives
AU2007221214A1 (en) * 2006-02-22 2007-09-07 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP1987034B1 (en) * 2006-02-22 2011-07-20 Vertex Pharmceuticals Incorporated Spiro condensed piperidines as modulators of muscarinic receptors
CN101500565A (zh) * 2006-06-29 2009-08-05 弗特克斯药品有限公司 毒蕈碱性受体的调节剂
AU2007284548A1 (en) * 2006-08-15 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP2051715A2 (en) * 2006-08-18 2009-04-29 Vertex Pharmceuticals Incorporated Modulators of muscarinic receptors
US7973162B2 (en) * 2007-10-03 2011-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
CN113264949B (zh) * 2021-05-31 2022-04-05 西南大学 一类螺苯并噁嗪哌啶α,β-不饱和酮类衍生物的设计合成与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA952908A (en) * 1970-02-27 1974-08-13 Yoshitomi Pharmaceutical Industries Benzodioxane derivatives
FR2420536A1 (fr) * 1978-03-22 1979-10-19 Roussel Uclaf Nouveaux derives de 1,3-dihydro 3-/1-/2-(2,3-dihydro 1,4-benzodioxin-2-yl)2-hydroxyethyl/piperidin-4-yl/2h-indol-2-one, procede pour leur preparation et application comme medicaments

Also Published As

Publication number Publication date
KR830010115A (ko) 1983-12-26
FI821733A7 (fi) 1982-11-19
PT74912B (en) 1983-12-07
ES8404791A1 (es) 1984-06-01
JPS57193485A (en) 1982-11-27
ES8404790A1 (es) 1984-06-01
PH20072A (en) 1986-09-18
BR8202861A (pt) 1983-04-26
ZA823414B (en) 1983-12-28
PL236472A1 (en) 1984-07-30
FI821733A0 (fi) 1982-05-17
IL65801A (en) 1985-09-29
NZ200631A (en) 1985-10-11
EP0065864A1 (en) 1982-12-01
IE53034B1 (en) 1988-05-11
PT74912A (en) 1982-06-01
ES521125A0 (es) 1984-06-01
NO821616L (no) 1982-11-19
ATE15198T1 (de) 1985-09-15
IL65801A0 (en) 1982-08-31
US4349549A (en) 1982-09-14
DK221882A (da) 1982-11-19
PL246771A1 (en) 1984-10-22
ES521124A0 (es) 1984-06-01
EP0065864B1 (en) 1985-08-28
AU8376982A (en) 1982-11-25
DE3265802D1 (en) 1985-10-03
HU186933B (en) 1985-10-28
ES512275A0 (es) 1983-12-01
IE821179L (en) 1982-11-18

Similar Documents

Publication Publication Date Title
ES2086643T3 (es) Derivados de camptotecina solubles en agua.
ES2031876T3 (es) Un procedimiento para la preparacion de 5,6-dihidro-2-(fenil sustituido)-1,2,4,-triazin-3,5(2h,4h)-dionas.
GR37262B (el) Μεθοδος δια την παρασκευην νεων βιολογικως ενεργων παραγωγων της πιπεραζινης.
ES2132751T3 (es) Compuestos de oxazol heteroaromaticos y su uso.
DK245888D0 (da) 4-aminoquinolinderivater
ES2033049T3 (es) Procedimiento para preparar derivados de oxa- o tia-zolina.
ES512842A0 (es) "procedimiento de preparar derivados carboxamidicos".
ES2093399T3 (es) Nuevos derivados de acido fosfono-succinico, procedimiento para su preparacion y medicamentos que contienen estos compuestos.
RU94030812A (ru) Производные фосфоноянтарной кислоты, способ их получения и содержащие эти соединения фармацевтические композиции
UY24482A1 (es) Quinoxalinadionas
ES2009785B3 (es) Procedimiento para preparar derivados de tioxantona.
ATE91625T1 (de) Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.
SE8505887D0 (sv) Indoler
ES8604922A1 (es) Procedimiento para la preparacion de n-piridilindoles
ES2032570T3 (es) Derivados antiparkinson de ergolina. (reserva del art. 167.2 cpe).
ES8504805A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepinas
PH18686A (en) 1-(3 halo-2-pyridinyl) piperazine
ES2090012T3 (es) Derivados de propoxibenceno y procedimiento para la preparacion de los mismos.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
ES2036533T3 (es) Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
ES2165410T3 (es) Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES8707738A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihidroorotil-histidil-prolinamida
ES2054186T3 (es) Composicion antihepatopatica.
ES2078497T3 (es) 6,7-disubstituidas-2-aminotetralinas activas como inmunomoduladores y composiciones farmaceuticas que las contienen.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001